The impact of alpha-adrenergic stimulation on umbilical blood flow.
This study evaluated the effects of intranasal phenylephrine, an alpha-adrenergic agonist used for respiratory congestion, on uteroplacental blood flow. Twelve subjects were recruited from the Women's Clinic. Inclusion criteria were age greater than 18 years, singleton gestation, absence of medical illness and gestational age of 22-38 weeks. Phenylephrine (0.2 ml of 1% aq. solution) was applied to each nostril. Maternal blood pressure and pulse, umbilical artery velocimetry, and fetal heart rate were recorded prior to drug administration and at 5, 15, 30, 45 and 60 min after administration. There were no significant changes in maternal pulse, blood pressure or fetal heart rate. All subjects had normal baseline umbilical artery Doppler systolic/diastolic ratios. Eleven of 12 subjects demonstrated an elevation of the systolic/diastolic ratio consistent with vasoconstriction following administration. This elevation reached statistical significance at 30 min. Significant individual variation existed with regards to timing of maximal excursion of the systolic/diastolic ratio. The mean maximal change of the systolic/diastolic ratio was 1.57 +/- 1.25 (p < 0.001) ranging from -0.53 to 4.11. The use of over-the-counter alpha-adrenergic agents may result in decreased umbilical artery flow velocities. In high-risk pregnancies these medications may be contraindicated.